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INTRODUCTION 

Antigen presenting cells 
The immune system harbors three sets of professional antigen –presenting cells 
(APCs): dendritic cells, macrophages and B cells (and certain activated epithelial cells). 
Common for the three subgroups is that they constitutively express Major 
Histocompatibility Complex (MHC) molecule (1). The classical MHC class I and MHC 
class II molecules are polymorphic membrane bound glycoproteins that require peptide to 
maintain a stable conformation (2). Thereby the professional APCs can at all times present 
antigen. Other cells can also present antigen, as most nucleated cells express MHC class I. 
Other cells can express low levels of MHC class II or be activated to express MHC class II. 
They include fibroblasts, thymic epithelial cells, thyroid epithelial cells, glial cells, 
pancreatic beta cells and vascular endothelial cells (1). 
Foreign exogenous antigen will be endocytosed and processed by the APC, and 
displayed on MHC class II molecules on the cell surface. MHC class II will present peptide 
to CD4+ T helper, which become activated and can initiate immune responses. Another 
antigen-presentation pathway, the MHC class I dependent pathway, presents peptides from 
nuclear or cytosolic proteins to CD8+ T cells (1). The phenomena of “cross presentation” 
leads to the presentation of extracellular antigens on MHC class I molecules to CD8+ T 
cells (3). 
 
Dendritic cells 
Dendritic cells (DC) are classically viewed as the most efficient APCs: DCs express 
high levels of MHC class I and II (4,5), DCs are active APCs long after the initial pulsing 
with antigen (6), and only few DCs are required to activate a large number of T cells (7). 
Also DCs constantly sample the micro environment by extending and retracting dendrites 
(8). There is a broad tissue localization of DCs, being distributed in non-lymfoid tissue 
either in tissues in contact with the external environment or interstital zones of heart, 
kidney and gut. Following activation, DCs migrate to lymphoid organs (1). 
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B cells 
B cells are classically not regarded as very efficient APCs: there is a low frequency 
of naïve B cells with specific receptor for any particular antigen. B cells can internalize 
antigen by: phagocytosis, fluid phase pinocytosis and receptor mediated endocytosis. B 
cell receptor (BCR) mediated endocytosis, can be a highly efficient process. Batista and 
Neuberger demonstrated that BCR/antigen affinity is directly proportional to the B cell 
ability to present antigen, and at high affinity BCR/antigen interactions, minor antigen 
concentrations are sufficient for uptake, presentation and Th cell activation (9). (see also 
the General discussion). 
 
B cell development  
B cells are generated from pluripotent hematopoietic stem cells during fetal 
development and in the bone marrow after birth. The bone marrow will hold B cells from 
early progenitors to mature B cells. A common lymphoid precursor gives rise to T-, B- and 
Natural Killer (NK) cells. As B cells mature in the bone marrow and eventually reach 
peripheral locations, they express a varying pattern of surface markers (see Table 1). 
Several nomenclature schemes have been proposed for developmental B cell stages 
(10,11).  
B cell development is dependent on the stromal cells for providing adhesion and 
soluble factors. B cell development is marked by successive steps in the rearrangement of 
variable (V), diversity (D), joining (J) and constant gene segments of the B cell receptor 
(see Fig.1) (1). The order of rearrangement according to the ordered model (Fig.1) is that 
heavy chains recombine first, followed by pairing with a surrogate light chain and 
thereafter light chain rearrangement (12-14). However evidence that this is not such a 
stingent process but that rearrangements occur independently is given in a stochastic 
model, for human (15) and mouse (16). As for kappa-, , and lambda-, , light chain 
expression, it is believed that there is sequential rearrangement and expression with a 
preference for  (17). In mouse 95% of peripheral Immunoglobulin (Ig) is  (18). Also in 
bone marrow  light chain expression outnumbers  light chain expression (19). 
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Figure 1. B cell lineage developmental stages are characterized by rearrangement and expression of Ig genes. 
Stem cell Ig genes are still in germline configuration (see Fig.3). Heavy chain gene segments arrange first in 
the order D to J, V to DJ. VDJ is assembled in late-pro B cells. A successful VDJ join, leads to expression of 
the μ chain, which is expressed mainly intracellularly at the Large pre-B ell stage with a surrogate light 
chain. Subsequently, light chain genes are rearranged at the small pre-B cell stage. When a light chain is 
assembled, the immature B cell will express the surface IgM molecule. Mature B cells produce both IgM and 
IgD from alternative splicing of mRNA (1). Figure adapted from (1). 
 
Once the BCR is assembled, immature B cells can undergo selection for self-tolerance. 
The antigen specificity of a B cell will be determined early in the differentiation, when 
variable regions assemble from gene segments. When assembled, the affinity and 
specificity of the BCR is tested by binding to antigens in the immediate environment. 
Receptors that bind weakly with self antigen are positively selected, and receptors that bind 
strongly are negatively selected, leading to cell death (1). Hence a certain level of tolerance 
is established to self antigens. B cell tolerance is recognized as being less stringent than T 
cell tolerance, and it has become clear that peripheral immature B cells often possess 
autoreactive BCR (20). Surviving emigrant B cells become mature naïve B cells in the 
periphery, circulating between blood and lymphoid tissue, where they again can encounter 
antigen and be clonally selected in adaptive immune responses (see further details under 
“T cell – B cell collaboration”). 
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B cell subsets in the periphery  
Before differentiating into mature B cells, the B cells go through several 
transitional stages. Transitional (T) B cells comprise three subsets (21), all characterized by 
the marker CD93/AA4.1. There are five mature B cell subsets in mouse spleen (22). The 
bone marrow derived follicular B cells and marginal zone (MZ) B cells (together the B2 
population), which constitute the majority of splenic B cells. In addition come B-1a and B-
1b cells, which are minor subsets in spleen as well as the newly characterized regulatory B 
cell that shares some characteristics of the B1-a cells and MZ cells (23-25). These different 
subsets vary in terms of their location, ability to migrate, and in the likelihood that they 
will be activated in a T-dependent or a T-independent fashion (all except the newly 
characterized regulatory B cell reviewed in (26,27)). The surface marker profile and 
frequency in spleen for these five subsets is given in Table 1. MZ and B-1 cells have been 
extensively characterized. 
 
Marginal zone B cells 
In rodents, MZ B cells are located, mainly around the marginal sinus of the spleen, 
a localization promoted by Sphingosine 1-phosphate receptor (28). MZ B cells are 
involved in antigen transport from the marginal zone into the splenic follicles, a function 
that has been linked to their high CD21 expression (29). MZ B cells can participate in T 
independent antigen responses (30). Reports show that MZ B cells are more prone to T 
independent activation and generate effector cells more readily than the follicular B cells 
(31). MZ B cells are also involved in T dependent antigen responses both by transporting 
antigen to follicular B cells, but also directly by presenting antigen to Th cells (32). Several 
experiments suggest that the MZ compartment is more permissive to self reactive B cells 
than the follicular compartment (33-35).  
 
B-1 cells 
The term “B-1 cells” was used to describe a subset of peripheral B cells developing 
earlier than follicular B cells in B cell ontogeny (36). The B-1 cell population includes B-
1a cells, which express CD5, and the B-1b cells, which are CD5 negative (37-40). B-1a 
and B-1b cells both reside mainly in the peritoneal and pleural cavities but have different 
functions. B-1a cells contribute to innate-like immunity and B-1b cells contribute to 
adaptive immunity (41,42). Similar to MZ B cells, B-1 cells constitute a population of cells 
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that are enriched for self-reactive B cell receptors (43). B-1 cells, as MZ B cells, readily 
generate effector cells in early stages of an immune response (44). 
Table 1 
   
Table 1 adapted from (22) 
The B cell receptor  
The two last exons of each constant gene segment in the HC Ig locus, contain 
secreted and membrane bound form respectively. If the membrane exon is not spliced off, 
the Ig exists in the membrane bound form of the BCR. The BCR consists of an antigen-
binding Ig with no direct signaling ability. The accompanying heterodimer Ig (CD79a) 
and Ig (CD79b), contains the cytoplasmic activation motif, “immunoreceptor tyrosine-
based activation motif” (ITAM), capable of signaling (1). Upon antigen binding to BCR, 
the tyrosines in ITAM sequences are phosphorylated. This is done primarily by the kinase 
LYN. Subsequently, SYK is recruited to the phosphorylated Ig-Ig heterodimer, with the 
triggering of at least four different signaling cascades (45).  
Antigen binding to BCR, arrests the free diffusion of the BCR monomers in the 
plasma membrane and triggers BCR organization into signaling clusters (46,47). Antigen 
induced BCR clustering enables phosphorylation of ITAMs and thereby triggers signaling. 
The efficiency of this process is limiting for the degree of B cell activation (48). 
It has been demonstrated that isotype switched IgG enhances BCR oligomerization 
and thereby signaling due to the 12 membrane proximal residues of the H chain tail (49). 
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In addition to increased affinity due to somatic hypermutation, this mechanism may 
explain why IgG isotype switched B cells are more efficient than non-switched B cells in 
vivo (50,51). 
 
Antigen processing, the endocytic pathway 
APCs internalize extracellular material by several different mechanisms 
collectively termed endocytosis. One of the best characterized endocytic mechanisms is 
receptor mediated endocytosis via clathrin coated pits (52).  
 
Clathrin dependent Receptor mediated endocytosis¨ 
Receptor mediated uptake by clathrin coated pits is a pathway used for processing 
ligand/receptor complexes. The uptake is initiated by internalization motifs in the 
endocytic receptor cytoplasmic tail (53-55). Adaptor proteins mediate formation of the pits 
(56). Clathrins organize into basket-like structures on the cytoplasmic side of membrane 
and form vesicles. A signal transduction pathway including the Vav1 and/or Vav3 protein 
isoforms and the GTPase dynamin has been shown to mediate BCR/ligand internalization 
(57). There are a large number of endocytic receptors on DCs: FcRs (58,59), heat shock 
protein receptors (60,61), scavenger receptor (CD36) (62), mannose receptor (63). 
 
Non clathrin mediated endocytosis 
“Phagocytosis” is the cellular uptake of large particles mediated by cell surface 
receptors and actin (64). Receptor binding may occur directly, or indirectly by 
opsonization, (coating of the particle with Ig or complement and subsequent receptor 
binding). The “zipper” model is a widely accepted description of the mechanism of 
phagocytosis (65). This involves engulfment of particles via extended membrane 
pseudopods, with a subsequent recruitment of surface receptors interacting with opsonins 
or proteins on the engulfed particles. After engulfing antigen, the two pseudopods fuse and 
budd off into an early endosome (66). 
Another type of non-clathrin mediated endocytosis is macropinocytosis. This 
closely resembles phagocytosis. However macropinocytosis has not been reported to 
concentrate receptors (67).  
 
7

Antigen processing and loading onto MHC class II molecules, BCR mediated uptake as an 
example 
BCR mediated uptake allows antigen to be presented on MHC class II molecules. 
The first step in the processing is internalization of the BCR antigen complex (68). The 
antigen is then proteolytically processed and can subsequently be loaded onto MHC class 
II molecules (69). Antigen degradation in the endocytic pathway occurs in a gradually 
more acidic and reducing environment in the endosomal/lysosomal vesicles. Endosomal 
acidity is maintained by ATP dependent protein pumps (70). Several proteases are required 
for generation of antigenic peptides (71,72). 
The MHC class II molecule is synthesized in the endoplasmic reticulum (ER), 
whereupon it is complexed to the Invariant chain molecule (Ii) in a specific conformation 
(73). This binding prevents the binding of ER-peptides prematurely (74). Ii accompanies 
the MHC class II molecule through the golgi complex to the endosomal compartments (1). 
In a particular subpopulation of the endosomal compartments the MHC class II associated 
invariant chain is removed by the action of proteases and the protein HLA-DM/H-2M (75) 
(human version). The resulting peptide loaded MHC class II can continue to cell surface. 
In mouse B cells, antigen processed via the transferrin receptor is presented 10-100 times 
less efficiently than same antigen processed via the BCR (76). This feature is possibly due 
to the transferrin receptors limited access to intracellular MHC class II compartments (77). 
Traditionally, distinction has been made between MHC class II molecules on APCs 
,exclusively presenting exogenous antigens, and MHC class I molecules presenting 
proteasome degraded “self” cellular components or intracellular pathogens that are loaded 
onto MHC class I in the ER. Hence the classical pathways for presentation of exogenous 
and endogenous antigen; have been termed the endogenous (MHC class I associated) and 
exogenous (MHC class II associated) pathways, respectively (1). However, more recent 
reports show that endogenously synthesized antigens are also presented on MHC class II 
molecules (78-80). Peptides eluted from MHC class II molecules are in fact mainly 
secretory pathway peptides produced from endogenously produced proteins (81-83).  
 
Immunoglobulins 

By dissociation of the Ig monomer by reducing disulfide bridges, it was determined 
that Immunoglobulins (Igs) consist of two identical heavy chains (~50 kDa) and two 
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identical light chains (~25 kDa) (H2L2) (84). The antigen binding site of Ig is composed of 
three loops within the H and L chain, called the hypervariable regions 1-3 or 
complementary determining regions 1-3 (CDR1-3). The variable and constant regions (see 
Fig.2) of the Ig can be classified into the following structural entities; Fragment Antigen 
Binding, Fab and Fragment crystallizable, Fc, respectively (85). Ig structure is given in 
Fig.2. 
  
The constant regions of the Heavy chain (HC) and light chain (LC) (Fig.2) can be 
of different isotypes: for LC  or  and for HC, in mammals; IgG, IgM, IgA, IgD and IgE 
and in addition the subclasses IgG1, IgG2, IgG3, IgG4, IgA1 and IgA2 in humans (1). The 
HC isotypes will be further discussed under “Immunoglobulin functions”. 
 
Immunoglobulin diversity 
As shown in Fig.2, the paired variable domains together constitute the antigen 
specificity of the Ig. The term idiotope (Id) is used for the variable region antigenic epitope 
of an individual Ig. The total Id repertoire in humans has been estimated to 1011 (1). This 
multitude of Ids is achieved by several processes i) combinatorial variation, due to 
combination of different gene segments in the Ig HC and LC locus (86), ii) junctional 
diversity, as a result of the template independent addition or deletion of nucleotides at the 
joints of the joined segments(1,87), iii) combinatorial diversity as a function of possible 
HC and LC chain V region pairings (1) and iv) the process of somatic hypermutation that 
introduces point mutations in rearranged V genes, secondary to antigen dependent GC 
Figure 2. Ig structure. Fab fragments [1] are 
joined to the Fc region [2] by the hinge region 
[6]. Each HC [3] holds one amino terminal 
(NH2) variable region (light blue) and three 
carboxy terminal (COOH) constant regions 
(darker blue). Each LC [4] also holds an NH2 
terminal variable region (light green) and one 
COOH terminal constant region (dark green). 
The two identical HCs are bound to each other 
covalently by disulfide bridges (-S-S-). The V 
regions of the HC and LC combined constitute 
the antigen specificity of the Ig [5, stipled red 
circle]. The figure is copied from 
http://en.wikipedia.org/wiki/Antibody 
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formation (88). The assembly of antigen receptor genes is mediated by a V(D)J 
recombinase consisting of RAG-1 and RAG-2 proteins (89,90). This RAG complex targets 
recombination signal sequences (RSSs) flanking all Ig gene segments (91). The V(D)J 
recombination process is performed stepwise as shown in Fig.1. 

The immunoglobulin locus in mice (and humans) 
The murine Ig HC locus is 3 million bases in size and is located on chromosome 
12. The murine Ig LC locus is located on chromosome 6 and 16 for  and  respectively 
(92). Within the genus Mus musculus, the Ig loci are highly polymorphic (93). The Ig HC 
loci of inbred strains have been assigned to different haplotypes (94). The BALB/c strain 
used for generation of knock-in (KI) mice herein has the Ig HC a haplotype (95). A 
comparison of the murine and the human Ig locus (HC + LC) is given in Fig.3. As far as 
possible IgH and IgL chain V (D) and J gene segments are given for BALB/c (only 
partially annotated as of today).  
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Figure 3. The murine and human HC and LC Ig locus. A. Murine IgH and IgL locus organization. Ig HC V 
genes:128 V genes, whereof 49 are functional (96). Ig HC D genes: 17 genes where of 14 are functional 
(92,97). Ig HC J genes: 4 functional genes (98). Constant region: 8-9 functional genes, only 8 shown (92). 
For murine  LC locus: 174 V genes have been annotated, whereof 94-96 are functional, 5 J genes, whereof 4 
are functinal and 1 functional constant gene (92). For Ig LC  locus there are 3 functional V genes arranged 
in two clusters, 5 J genes, whereof 3 are functional (p = pseudo gene), and 4 constant genes whereof 2-3 are 
functional (92,99). B. Human Ig HC and Ig LC locus organization. HC V genes: 123-129 genes, whereof 38-
46 are functional. HC D genes: 27, whereof 23 are functional. HC J genes: 9 genes whereof 6 are functional. 
HC constant genes: 9 functional genes (of 11 genes, only functional genes are shown). For human  LC locus 
there are 76 V genes whereof 31-35 are functional, 5 functional J genes and one functional constant gene. For 
human  locus there are 73-74 V genes whereof 29-33 are functional, 7-11 J and constant genes in clusters, 
whereof 4-5 (J-constant) clusters are functional (92). Color codes: V = black, D = green, J = red, constant = 
yellow. Dots signify that not all gene segments are shown with boxes. 
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Immunoglobulin function 
Ig effector functions, are partly determined by the Ig Fc region. The effector 
function depends on the isotype ability to i) bind specific Fc-receptors (FcR) on cell 
surfaces, ii) activate the complement system and iii) form oligomers (see Table 2). The 
organization of the isotype determining constant gene segments of the IgHC locus is 
shown for mouse and human in Fig.3. IgM is expressed on the surface of almost all mature 
B cells, with the coexpression of IgD. μ and  genes are both transcribed from the VH 
promoter, so RNA splicing will yield either IgM or IgD. The process of isotype switching, 
which yields other isotypes than IgM/IgD, involves a process of irreversible DNA 
recombination (1). Isotypes have distinct structures, biological activities and distributions 
in the body, listed in Figure 4 (structural differences have been simplified). IgM and IgA 
are usually present as mulitmers in association with the polypeptide J-chain. The different 
isotypes also vary in positioning and number of linking of disulfide bonds, and degree of 
amino terminal (N)-linked carbohydrate groups (1). 
The Ig Fc/FcR interaction, is an important mechanism mediating Ig effector 
function. For example, IgG antibodies (Abs) bind the FcR on macrophages and 
neutrophils, mediating phagocytosis of opsonized microorganisms and/or secretion of 
cytokines involved in inflammation. IgE Abs induce the release of chemical mediators 
from mast cells and basophils by binding to the FcR (Fig.4) (1). Though FcRs able to bind 
IgM have been characterized in humans (100) and mouse (101), and also Fc receptors for 
IgA in humans (102), these receptors are not as well characterized as FcRs for IgE and 
IgG. There is also recent report of possible receptors for IgD in humans (103).
IgG is the only Ig capable of crossing the placenta giving immunity to the human 
fetus, by means of the neonatal FcR (FcRn) (1). 
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Figure 4. Structure, characteristics and effector functions of Ig isotypes in human. 
Igs are composed of dimerized heterodimers of heavy and light chains.IgM and IgE lack the hinge region that 
provide flexibility, but they have an additional heavy chain domain. * = less characterized, see text. ADCC = 
Antibody dependent cell cytotoxicity. 
 
Idiotypes and the idiotypic network 

Individual Ig molecules carry unique V region antigenic determinants that are 
called idiotopes (104-106). In 1971 Sirinsinha and Eisen demonstrated that Ig from the 
MOPC 315 plasmacytoma was immunogenic: when syngeneic BALB/c were immunized 
with this Id+ Ig (in complete Freund’s adjuvant (CFA)), they observed an anti-idiotypic Ig 
response (106). To test if an antigen response in addition to generating antigen specific 
Abs, also would generate anti-idiotypic Abs to the antigen specific Abs, Rodkey performed 
following immunizations: first rabbits were immunized with hapten/carrier, then after 
purifying hapten specific Abs from serum, these were used to immunize the same rabbits 
again (107). Rodkey found that from the second immunization, anti-anti-hapten Abs 
resulted. In the wake of such findings, N.K Jerne postulated that the immune system 
functions as a network based on idiotypic interactions between lymphocytes expressing 
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complementary BCR (108). Jerne suggested that the network was maintained in a steady 
state due to a combination of stimulatory and suppressive interactions between clones. In 
this regard immunizing with Ig as above, would perturb the network.
A corollary of the network hypothesis, is that an Ab1 will through the anti-idiotypic 
Ab2 generate Ab3, which mimicks Ab1. This was tested and confirmed by Jerne (109). 
Firm evidence was given for these types of idiotypic cascades in the course of an immune 
response (110-112). These findings drew scientific attention across various fields, e.g 
several publications describing the idiotypic network with mathematical models were 
published in the 1970s and 1980s (113-116). 
Adding complexity to the idiotype network of BCR reactive Abs, T cells also 
express TCR idiotypes and thus they could be regulated by binding to other T cell 
idiotypes, or B cell idiotypes. Such suggestions were prompted by several experiments in 
the 1970s and early 1980s (reference only here given for a select few): (117-119). This 
would imply complex networks where B-B, T-B and T-T interactions are possible 
(120,121). The significance of such complex connectivity models lost much relevance 
when the role of the MHC molecule in initiating immune responses became clear. 
However the striking and robust phenomena observed in early studies of idiotypic 
networks have relevance to studies performed decades later. Recent reports show that the 
idiotypic-connectivity or the disturbed idiotypic-connectivity may play a role in 
autoimmune diseases (122-125). Further, the concept can be used to modulate the immune 
system and thereby treat disease, as shown for non small lung cancer (126) and 
autoimmune disease (127). 
The initial event in the pathogenicity of autoimmune disease is still not clear. It is 
possible that idiotype network may play a role, especially when considering Th cell-B cell 
interactions, see the discussion.  
 
 

  
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T lymphocytes, development and function 
 
T cell development 
The crucial events in T cell development occur in the thymus. Important subset-
defining T cell surface receptors are CD4, CD8 and T cell receptor complex molecules 
(CD3, and T cell receptor  chains). Immature thymocytes (T cells precursors) do not 
express these markers. Thymocytes may give rise to a minor :+ T cell subpopulation or 
:+ T cells. Thymocytes go through a step in which they express a preTCR, and after 
division become small resting CD4+/CD8+ double positive (DP) (1). 95% of these cells 
undergo apoptosis in the thymus (128).
The DP cells that express TCR that bind MHC class II/I, receive survival signals, 
migrate into the thymic cortex and differentiate into mature T cells (1,129). Strongly self-
reactive clones undergo apoptosis in a process termed negative selection (128). However, 
not all T cells with high self affinity are removed: it has been suggested that natural 
regulatory T cells require high affinity TCR binding (130). Negative selection is controlled 
by many molecules acting in concert (131,132). 
Weakly self reactive T cells are positively selected. Positive selection is aided by 
the CD8/CD4 molecules. According to the instructive model, DP cells recognize MHC 
class I-peptide, engage CD8 and downregulate CD4. Reciprocally, DP cells that recognize 
MHC class II-peptide, engage CD4 and downregulate CD8. The surface molecules TCR-
CPM, CD3-ITAM, CD3 are essential in initial positive signaling (131).  
Elimination of T cells in the thymus is termed central tolerance. T cells are also 
subject to peripheral tolerance. Peripheral T cells that are chronically exposed to 
MHC/peptide, will become anergic and non-responsive if costimulatory signals or 
inflammatory cytokines are lacking (1). Regulatory T cells also play a very important part 
in peripheral tolerance (133-135).  
 
CD8+ cytotoxic T cells  
Naïve CD8+ T cells that undergo priming in peripheral lymphoid organs through the 
MHC class I/peptide complex on APC, will differentiate into cytotoxic effector T cells. 
The priming of Naïve CD8+ T cells may require assistance by T helper cells (136). 
Cytotoxic T cells serve to monitor cells and tissue for viral antigen, and induce apoptosis 
of cells that present MHC class I/peptide (1).  
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CD4+ T helper cells 
Naïve CD4+ T cells that that are primed with peptide/MHC class II on APC, will 
differentiate into one of the T helper subsets.  
 
Th1 and Th2 
The classical T helper subsets are Th1 and Th2 (1). The manner that the innate 
immune system responds to an invading pathogen defines the cytokines that may impact T 
cell priming and the outcome of the T cell polarization. It is commonly accepted that 
immunological responses to intracellular pathogens (virus and some bacteria) favors Th1 
polarization, while responses to extracellular pathogens (e.g worms and allergens) favors 
Th2 polarization (1). It has also been suggested that the strength of the interaction of TCR 
with antigen/MHC may play a role (137).  
Th1 cells promote inflammatory innate immune responses by supporting 
macrophages and the production of opsonizing Ig subclasses in B cells. Th1 are 
charcterized by production of IFN. IFN- activates macrophages, inhibits Th2 
development, supports antigen processing and increases MHC expression on APCs (1).Th1 
cells also express Fas ligand (The Fas ligand-Fas interaction induces apoptosis of Fas 
expressing cells) (1). For Th1 effector functions, transcription factors (TFs) and cytokines, 
see Figure 5. 
Th2 cells express the GATA3 transcription factor and are important in the adaptive 
immune response. Th2 are specialized for B cell activation: they produce IL-4, IL-5, IL-
13and IL-15 that are potent B cell stimulatory factors. The Th2 cytokines IL-10 and TGF 
inhibit Th1 polarization (1). For Th2 effector functions, transcription factors and cytokines, 
see Figure 5. 
 
Th17 
Th17 play an important role in clearance of extracellular pathogens, especially at 
mucosal surfaces (138). It is believed that they play a key role in localized focal 
autoimmune diseases (139,140). Several factors have been identified as being involved in 
Th17 development; TGF, IL-6, IL-21, IL-23 and transcription factors STAT3, RORT 
and ROR, as reviewed in (138). See Figure 5 for Th17 effector functions, cytokines and 
transcription factors. 
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T follicular helper (Tfh) 
Tfh are a T cell subset involved in the activation of B cells in the germinal center 
(GC) reaction (see “Th cell - B cell collaboration”). Tfh cells express high levels of the 
chemokine receptor CXCR5 which contributes to the co-localization of Tfh and B-cells in 
follicles (141,142). Tfhs require IL-21 for generation (143). The transcriptional repressor 
Bcl-6 has been used to distinguish the Tfh subset from other Th cell subsets. Moreover, 
Tfhs are PD-1high and ICOS+ (144). See Figure 5 for further details. 
 
Regulatory T cells, Tregs 
Treg cells are important in maintaining immune homeostasis, and preventing 
detrimental T cell responses (133).Their dysfunction may be involved in autoimmune 
disease, immune pathology and allergy (145). The Treg subset is commonly distinguished 
by the forkhead transcription factor (FOXP3) expression (146). The two major classes of 
FOXP3 Tregs are classified as CD4+/CD25+ naturally occurring Tregs (nTregs), originating 
directly from thymus, and Tregs derived from primed naïve Th cells under the influence of 
TGF. This latter Treg type is called induced Tregs (iTregs) (147). See Figure 5 for further 
details. 
 
T helper subset plasticity 
There is some plasticity to the profile of T helper subsets. Th17 cells may convert 
to Th1 cells (148). Th2 can also become IL-9 secreting cells (adapting a Th9 profile, not 
addressed herein) (149). Also Th2 cells have been shown to transform into CXCR5+ Tfh 
cells (150). FOXP3+CD4+ T cells have also been shown to differentiate into Tfh in peyer’s 
patches (151), thus becoming an effector cell no longer suppressing but promoting immune 
responses. 
The classical view has been that T helper lineage commitment is unidirectional and 
fixed for Th1- and Th2 cells, and that these express a unique cytokine and TF profile. With 
the discovery and characterization of new subsets such as Treg and Th17, the classical view 
is being reshaped. An overview of Th lineage development and characteristic factors and 
functions is given in Figure 5. 
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Figure 5: Development and characteristics of the CD4+ T cell lineage. When primed by APC in the 
periphery, naïve CD4+ T cells, depending on help from the cytokine environment, differentiate into one of 
five subclasses: either the classical Th1, Th2 or the more recently discovered Th17, Tfh and induced Treg 
(iTreg). Transcription factors are given in italics 
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Cytokines 
The cytokine environment is of crucial importance for adaptive and innate immune 
functions. Cytokines effect lymphoid proliferation and survival, antigen presentation and 
trafficking in cells, and organogenisis of lymphoid organs. Moreover, the cytokines 
interface with peptide hormones of the central nervous system (1). An updated list of 
cytokines, with their source and function, is given in Table 2.  
Table 2. Cytokines; source and effect in the immune system. Adapted from 
http://themedicalbiochemistrypage.org/, Michael W. King, PhD/IU School of Medicine. 
  
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Th cell - B cell collaboration 

Th cell - B cell collaboration is a central part of the adaptive immune response 
(humoral immunity). In a typical immune response, B cells and CD4+ T cells (T follicular 
helper cells, Tfh) interact in the germinal center (GC) of peripheral lymphoid organs to 
produce somatically mutated, high affinity, predominantly isotype switched Ab (152) that 
aid in the clearance of pathogens. This response persists partly through secretion from long 
lived plasma cells (153). Another outcome of this Th cell - B cell collaboration is the 
formation of long lived memory B cells (154), enabling the rapid response upon re-
exposure to antigen by differentiating into plasma cells (155). 
 
Historical milestones towards our understanding of T cell -B cell collaboration 
Key observations on Th cell - B cell collaboration, were done in the 1960s, where 
thymectomy inhibited Ab production, thereby demonstrating the importance of T cells 
(156). Transfer of B cells (bone marrow cells) and T cells (thymus cells ) into irradiated 
hosts showed that both were necessary for Ab formation: single transfers abrogated Ab 
production (157). Simultaneously the role of “carrier proteins” in Ab production was being 
elucidated. Haptens are unable alone to mount Ab responses, but can do so when coupled 
to so-called carrier proteins. Transfer experiments demonstrated that spleen cells from 
donors immunized with the carrier protein bovine serum albumin (BSA), when transferred 
into another mouse of the same strain, help co-transferred lymphocytes, identified as 
thymus derived, from an animal immunized with 4-hydroxy-3-iodo-5-nitrophenylacetitc 
acid (NIP)-conjugated to ovalbumin, to produce NIP specific antibodies when immunized 
with NIP-BSA (158,159). Earlier experiments also demonstrated that in the immunization 
with hapten conjugates, it was a requirement for Ab responses that the antigen had more 
than one antigenic determinant (160). In summary, antigenic determinants (epitopes) 
recognized by T and B cells must form part of the same structure. This led to the concept 
of an “antigen bridge” that was necessary for antibody production. When the T cell marker 
Thy1 was discovered, the marker was used to definitely show that the carrier specific 
population were T cells (161,162). These studies were followed by the discovery of the 
role of MHC class II molecules (163), the cloning of the TCR and the demonstration of 
peptide loading onto MHC molecules of B cells (164), largely progressing our 
understanding of the mechanisms of Th cell – B cell collaboration.   
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Events leading to the GC formation 
T dependent B cell memory requires CD4+ Th cell and B cell contact in GCs within 
the follicles of lymphoid organs (165). Initial events leading to the GC formation are 
summarized in Figure 6. T-dependent Ab responses are initiated when rare B and Th cells 
specific for an antigen interact in the T cell - B cell boundary (166). Thereafter, the B cells 
either move into the extra follicular areas as short lived plasma cells or migrate into the GC 
(167).  
 
Figure 6. Events leading to the formation of germinal centers. Naïve B cells enter the lymphoid organ 
through High endothelial venules (HEV). The entering B cells will migrate in the follicle dependent on 
expression of chemokine receptor CXCR5. CXCR5 is expressed on all mature B cells (168) and its ligand 
CXCL13 is made by follicular stromal cells in the subcapsular region of the follicle and follicular dendritic 
cells (FDCs) in the center of the follicle (169,170). Naïve B cells also express CCR7, the receptor for CCL21 
and CCL19. CCL21 and CCL19 are expressed in T cell zones (171) and CCL21 extends into lymphoid 
follicles in a decreasing gradient (172). Antigen specific T cells primed on dendritic cells in the T cell zone 
upregulate ICOS, PD-1 and CXCR5 and migrate towards the T-cell/B-cell interface zones. In areas forming 
primary foci, T cells can interact with B cells. If a B cell receives cognate T cell help, there will be a 
proliferative burst. At his point some B cells are fully activated and secrete mainly IgM. Other B cells will 
upregulate CXCR5 and migrate according to the increasing gradient of CXCL13 and form GC B cells. 
Antigen specific T cells primed on DC in T cell zone, upon interaction with a cognate B cells becomes Thfs. 
T cells upregulate CXCR5 to enable follicular localization.* = this interaction will be elucidated. GC B cells 
emigrate from the follicle and differentiate into long-lived plasma cells and memory B cells. 
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The germinal center 
Contrary to previous dogma, it has been revealed that the germinal center is an 
open and dynamic organ, where both antigen-specific and non-specific B cells may enter 
(173).  
The nature of this process has not been completely understood, however it is believed that 
high affinity BCR cross-linking favors plasmablast formation (174). Also the long-lived Th 
cell - B cell cognate contacts may be fate determining (175). As the GC matures two 
compartments become distinct. These compartments were first described based on their 
histological appearance (176); the light and the dark zone. GC B cells in the dark and light 
zone were classified as centroblasts and centrocytes respectively, each with specific 
characteristics (177). Real-time imaging has lately given a lot of new data, and challenged 
many of the previous ideas (173). The GC reaction as it takes place in the light zone and 
the dark zone has been summarized in Figure 7. In the light zone Follicular Dendritic Cells 
(FDCs) accumulate, with distinct features from FDC in primary follicles; upregulated 
VCAM-1 and Fc (178,179). The light zone seems to be positioned towards the 
source of foreign antigen (180) and antigen is transported rapidly to the light zone (181). 
CXCL13 is more abundant in the light zone, and CXCL/CXCR5 is necessary for 
accumulation of GC B cells to accumulate in the light zone (182). The chemokine receptor 
CXCR4 is needed for GC B cells to locate to the dark zone and its ligand SDF-1 is more 
abundant in the dark than light zone (182). As for Tfh cells, they are much more abundant 
in the light zone than the dark zone (183) and are characterized by expression of CXCR5 
and ICOS (183). Tfh cells interact preferentially with B cells displaying the highest levels 
of MHC class II and induce them to move to the dark zone for proliferative expansion 
(184). GCs can form independently of cognate interactions with Th cells, but these GCs 
collapse shortly after compartmentalization into dark and light zones (185). GC B cells 
have been estimated to be 5-20 times more abundant in GCs than T cells, but less than one 
third of T cells were moving at a speed permissive of T cell - B cell conjugates (181). This 
suggests that there would be high competition of GC B cells for cognate Th cell help. This 
competition for Th cell help has been suggested as an effective mechanism of achieving 
high affinity clones (186).  
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Figure 7. Cellular composition and function of dark and light zones in the germinal center (see text for 
references). GC B cells accumulate in the dark zone after mitosis. Somatic mutation may also occur here. 
After mitosis, B cells down-regulate CXCR4, cells can leave the dark zone and enter the light zone by a 
CXCL13 gradient. Here, the B cells move around the FDC network, where the B cells could receive survival 
signals and also endocytose, process and present Ag removed off the surface of FDCs. Subsequently B cells 
would compete for Th cell help. Cells entering the light zone undergo apoptosis, exit the GC or return to the 
dark zone. Cells exiting the GC differentiate into long-lived plasma cells or memory B cells. Tingible body 
macrophages are macrophages that have engulfed the nuclei of dead B cells (187). 
 
Molecular interactions between Tfh and GC B cells and downstream events 
Antigen specific Th cells primed on DCs in the T cell zone, may up-regulate ICOS, 
PD-1 and CXCR5 and migrate towards B cell follicles, where an interaction with B cells 
(in a IL-21 associated process) may allow cells to express Bcl-6 and become Tfh cells. 
Certain molecules have been shown to be a requirement for the Tfh - B cell interaction in 
the GC. ICOS and CD40L are absolutely required for Tfh cell differentiation and thus GC 
development (188). CXCR5, the adaptor SAP and cytokines such as IL-21 and IL-4 are 
partially required for Tfhs. GCs that arise in their absence are in varying ways defective 
(142,154,189). The absence of IL-27 receptor has a detrimental effect on Tfhs as they do 
not expand normally and produce less IL-21 (190). Some of the important molecules in the 
Tfh - GC B cell interaction are given in Figure 8.  
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Figure 8. TheTfh - B cell molecular interaction in the GC. Molecular pairings culminate in the T cell 
secreting cytokines, particularly IL-4 and IL-21. 
 
Conventional (“linked”) vs non-conventional (“non-linked”) Id-driven Th cell - B cell  
Collaboration 

The previously introduced concept of the “antigen bridge” in T cell - B cell 
collaboration was later termed “linked” T cell – B cell collaboration (191). However 
interactions are possible that do not conform to this norm. For example, in mixed 
lymphocyte reactions, alloreactive Th cells may be activated by allo-MHC, while B cells 
may be specific for unrelated antigen. In such Th cell- B cell collaboration, the interaction 
is not linked to a common antigen. Another example of non-linked Th cell – B cell 
collaboration was named “non-linked” Id-driven Th cell – B cell collaboration. For 
simplicity Th cell – B cell collaboration will be termed T cell – B cell collaboration. 
To explain this interaction, some premises must be presented: Our group 
(78,79,192) and others (193) have shown that B lymphoma cells (78,79), B cells from 
transgenic mice (192) and normal B cells (193) present BCR V region Id in a MHC class II 
dependent fashion to Id-specific Th cells, resulting in T cell proliferation and in turn B cell 
differentiation and Ab secretion (193,194). This Id-driven T cell - B cell collaboration is 
non-linked in the sense that the B cells and T cells do not recognize epitopes on the same 
antigenic entity. This chronic Id-driven T cell - B cell collaboration can lead to B cell 
lymphoma development (195) and autoimmune disease manifestations (196).  
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The “non-linked Id-driven” T cell - B cell collaboration described above, has been 
investigated in our group using the The 2315 model. This model has also been the basis for 
experiments reported in this thesis. 
 
The 2315 model 

The Id-specific Th cells in our experiments, are Th cells specific for the 2315 T cell 
epitope of the myeolma protein M315. The 2315 model has been employed extensively in 
our group to study the above mentioned Id driven “non-linked” Id driven T cell –B cell 
collaboration. The model system and all its components are given in Figure 9. 
 
Figure 9. The secreted M315 IgA mAb ( referred to as Id+ in our studies) of the MOPC315 plasmacytoma 
cell that arose in BALB/c after injection of mineral oil i.p (197), has three mutated aa in positions 94,95 and 
96 of the V gene region of  LC (198). Id-specific CD4+ T cells from BALB/c mice immunized with 2315 , 
that recognized a CD3 peptide spanning aa 91-101 in a MHC class II (I-Ed) restricted fashion were cloned 
(199-201). TCR -and  genes of the T cell clone 4B2A1 were used to generate TCR transgenic mice (202).  
  
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Apoptosis in a B cell tolerogenic perspective 
 
Autoreactive B cells can be deleted as one of several tolerogenic mechanisms (see 
general discussion). In the periphery, self reactive B cell clones can arise from Th cell 
dependent somatic hypermutation (203). Such clones would require elimination to avoid 
autoimmunity (204). Deletion of peripheral B cells with BCR specific for a membrane 
bound self-antigen has been demonstrated with transgenic mice (205). It has been 
suggested that for immature B cells in the bone marrow, the microenvironment supplies 
signals that favor receptor editing for autoreactive B cells, where the lack of these signals 
in the periphery would direct towards apoptosis (206). However also immature 
autoreactive B cells can undergo activation induced cell death (AICD) (207,208).  
 
The role of caspases in AICD 
BCR mediated apoptosis involves the activation of caspases (CysteineAsparthyl 
Specific Proteases), a family of cysteine proteases that cleave their substrates at aspartic 
residues (209). Caspases are classically grouped into the initiator caspases (caspase 2, 8, 9, 
10) and the effector caspases (caspase 3, 6, 7). Caspases are regulated at a post-
translational level, ensuring that they can be rapidly activated.  
Apoptosis has classically been separated into two pathways, one requiring 
activation of death ligands and receptors (210) and the other involving mitochondria (211). 
However later evidence shows that they are linked and that molecules can influence each 
other. A highly simplistic illustration of the two classical caspase activation pathways is 
given in Figure 10.  
BCR induced caspase activation is triggered independently of death receptors and 
caspase 8 (212). In primary B cells (209) and in mature (213) as well as immature (214) B 
cell lines, BCR mediated apoptosis has been suggested to be a result of the intrinsic 
apoptosis pathway of cytochrome c/Apaf-1/caspase-9, connecting the mitochondria to 
executioner caspases (215). 
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Figure 10.  Pathways for caspase activation: The extrinsic pathway, connects the cell- surface binding ligand 
to apoptosis induction by the Tumor Necrosis Factor (TNF) family of cytokine receptors such as TNFR and 
Fas (216), depicted as death ligand/receptor. The intrinsic pathway involves the participation of mitochondria 
(e.g induced by UV radiation), releasing caspase activating proteins into the cytosol and finally triggering 
apoptosis (217). Active caspase 8 and 9 have been shown to directly cleave and activate the effector protease 
caspase 3. Effector caspases 6 and 7 are only two of several effector caspases. The figure shows only a very 
simplified overview of the two main pathways for caspase activation.  
 
  
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AIMS OF THE STUDY 
 
To this day, the impact of the idiotype networks on the immune system is unclear. 
As advances in molecular biology have provided new tools, we can now use mouse models 
to study the basic mechanisms of idiotypic regulation under physiological conditions. 
Firstly we wanted to investigate how idiotype+ antibodies (Id+ Ab) and anti-
idiotypic antibodies (anti-Id Ab) could communicate in the context of interactions that also 
involved idiotype-specific Th cells. Could a B cell with anti-idiotypic BCR provide an 
efficient APC for idiotype-specific T cells when presented with idiotype+ Ig ?(paper1). 
How efficient would this mechanism be under physiological conditions? (paper3)  
It is unclear to what extent idiotype network interactions can occur in the absence 
of T cells. What would happen when B cells with complementary BCR idiotypes 
interacted? (paper2). Such interactions could potentially shape the early and late B cell 
compartments. 
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SUMMARY OF INDIVIDUAL PAPERS 
 
Paper 1: The cellular mechanism by which complementary Id+ and anti-Id 
antibodies communicate: T cells integrated into idiotypic regulation 
 
Johanne T. Jacobsen, Elin Lunde, Vibeke Sundvold-Gjerstad, Ludvig A. Munthe and 
Bjarne Bogen. 
 
In this paper we wanted to elucidate how Id-specific Th cells and anti-Id B cells 
presenting Id+ Ig, communicate. The issue is pertinent as the idiotypic connectivity in an 
individual to this day lacks a mechanistic explanation. Both in vitro and in vivo models 
were used: The in vitro model was B lymphoma cells expressing an anti-Id BCR (IgD, 
only membrane bound form), in context of Id-specific Th cells and Id+ Ig. The in vivo 
models were i) a surrogate model using Id-specific T cells, a recombinant Ig, harboring the 
Id+ peptide, directed to IgDa (anti-IgDa rIg) and BALB/c (IgHa) B cells, all transferred to 
C.B-17 (IgHb) recipient mice and ii) anti-IgDa recombinant Ig delivered to TCR transgenic 
mice (harboring Id-specific T cells). 
The in vitro model described above showed that the anti-Id B cells were x104 more 
efficient at presenting Id+ Ig to CD4+ Th cells. The anti-Id BCR was required for 
proliferation of Id-specific Th1/Th2 and effector functions of Id-specific Th1 cells in the 
presence of Id+ Ig. The surrogate in vivo models i) and ii) demonstrated that B cell 
proliferation and generation of anti-Id Abs was highly dependent on Id+ being targeted to 
the BCR (IgD). 
Conclusions: Our results demonstrated how Id+ Ig was efficiently presented to Id-
specific T cells by anti-Id expressing B lymphoma cells, thus activating the Th cells. The 
results further demonstrated that this idiotypic Th cell - B cell collaboration also applied to 
normal B cells in vivo, with Id+ being delivered to the BCR. The results of this paper were 
unphysiological. Hence, further investigations were merited in more physiological settings 
where Id+ Ig could be presented to Id-specific Th cells by normal B cells through bona fide 
Id+/anti-Id interactions. 
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Paper2: B lymphoma cells with mutually binding B cell receptors kill each other: a 
mechanism for reduced idiotypic connectivity?  
Johanne T. Jacobsen, Vibeke Sundvold-Gjerstad, Frode M. Skjeldal, Oddmund Bakke, 
Anne Spurkland and Bjarne Bogen. 
As an inevitable consequence of antibody diversity, B cells with complementary 
BCRs (defined by their respective idiotypes) will at some time interact. This could happen 
either in the bone marrow or in the peripheral lymphoid sites. To our knowledge, this issue 
had not been studied. In order to investigate the issue, we resorted to using B lymphoma 
cells in a model system. We generated A20 B lymphoma cells expressing complementary 
sets of BCR, enabling Id+/anti-Id interactions (“anti-Id” A20 was generated in paper 1). To 
eliminate the confounding effect of secreted Ig, we restricted the idiotypes to membrane 
expression by excising the secretory exons. In a range of different assays we demonstrated 
that Id+/anti-Id (BCR/BCR) interaction of these cells resulted in apoptosis. Both cell types 
were prone to apoptosis, but overall the Id+A20, with a lower BCR density than anti-Id 
A20 was more susceptible. Also, in conjugates of Id+/anti-Id B cells, it appeared that only 
one cell would receive an apoptosis signal (caspase activation). The Id+/anti-Id BCR/BCR 
interaction was also compared to Id+/anti-Id BCR/Ig interactions (for both Id+A20 and anti-
Id A20). We observed that the BCR/BCR interaction was more efficient at inducing 
apoptosis. We also observed that apoptosis induction with Ig/BCR adhered to conventional 
activation induced apoptosis: a higher BCR density conferred increased apoptosis. 
Conclusion: Our results suggested that the Id+/anti-Id BCR/BCR induced apoptosis 
could be an efficient tolerance mechanism restricting the B cell repertoire. The outcome 
could depend on many factors such as: BCR density, Id+/anti-Id affinity, activation state 
and subset of the B cell and amount of secreted Ig. A physiological model to further 
investigate the mechanism is not currently available.  
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Paper 3: Anti-Id B cells and Id-specific CD4+ T cells collaborate efficiently under 
physiological conditions.  
Johanne.T Jacobsen, Ludvig. A Munthe, Karoline W. Schjetne and Bjarne Bogen. 
Moving towards a more physiological situation and answering some of the issues 
described above, we here used a novel Ig receptor knock-in mouse. This mouse was 
generated in the current work. The anti-Id Ig knock-in mouse on a BALB/c background 
(resulting from a cross of anti-Id IgH knock-in and anti-Id IgL knock-in) expressed the 
anti-Id BCR on almost all B cells. The B cells demonstrated enhanced development in 
bone marrow, most likely due to the pre-rearranged BCR. Anti-Id mice demonstrated a 
normal B cell subset distribution in the periphery. There were no signs of an abnormal 
phenotype in this mouse. Using B cells from this knock-in mouse with Id-specific CD4+ T 
cells and Id+ Ig, we demonstrated (in vitro and in vivo), that the “linked” idiotype-specific 
T cell - B cell collaboration was highly efficient. We demonstrated that this specific 
interaction was initiated even with naïve T cells, and that low numbers of cells and small 
amounts of Ig were sufficient to elicit responses. In vivo, anti-Id isotype switching and GC 
formation was observed. 
Conclusion: Our findings in this paper offer a physiological model explaining the 
basic mechanism of idiotypic connectivity. Our results suggest that small numbers of anti-
Id B cells and Id-specific Th cells can interact in presence of low concentrations of Id+ Ig, 
in an unprimed physiological setting. 
  
31

METHODLOGICAL CONSIDERATIONS 
 
Transgenic mice (paper 1 and 2) 

Id-specific TCR transgenic BALB/c and TCR transgenic SCID (CB.17 scid/scid) (paper 1 and 
3) 
A TCR transgenic (TCR TG) mouse was generated from the TCR  and  genes 
(V1, J19; V8.2, J1.2) of the T cell clone 4B2A1 (202). This TCR TG mouse has CD4+ 
T cells responding to the 2315 light chain of the MOPC 315 protein M315 in a MHC class 
II restricted manner. Both TCR TG BALB/c (202) and TCR TG SCID (CB.17 scid/scid) 
(218) were used in our experiments.  
The TCR TG BALB/c holds totally lower numbers of cells in spleen and lymph 
nodes compared the non TG BALB/c. However, TCR TG BALB/c Id-specific T cells seem 
to have a normal phenotype. TCR, CD4 and CD8 density on peripheral T cells of TCR TG 
and normal BALB/c do not differ (202). TCR TG SCID are unable recombine endogenous 
TCR or BCR genes (due to a defect in the DNA-dependent protein kinase catalytic subunit 
(219)), thus the number of cells in lymphoid organs is severely reduced. However, also 
TCR TG SCID show a normal expression of TCR, CD4 and CD8 on peripheral T cells 
(218). 
In TCR TG SCID the allelic exclusion of endogenous  and  chains is complete 
(218). However for T cells in TCR TG BALB/c, only a fraction express the transgenic , 
whilst almost all express the transgenic  (202). This is probably due to preferential  
pairing (220). The Id-specific T cells in TCR TG BALB/C that do express the transgenic , 
can also co-express endogenous , due to functional rearrangements. These cells make up 
the main fraction of Id-specific T cells in the TCR TG BALB/c and stain dimly with the 
clonotype specific mAb GB113 compared to Id-specific T cells from TCR TG SCID, 
which express only transgenic  (218). The double specificity Id-specific T cells 
(expressing endogenous  and transgenic ) in TCR TG BALB/c, have a reduced signaling 
capacity and response to 2315/I-Ed compared to Id-specific T cells expressing only 
transgenic  (221). The signaling capacity of the Id-specific T cells is a concern, especially 
in paper 3, where we tried to determine the lower threshold of cells and Id+ Ig needed to 
elicit Id-specific B cell and T cell responses. The anti-Id B cell/Id-specific T cell responses 
in the presence of Id+ Ig, could in fact be more sensitive with Id-specific T cells from TCR 
TG SCID. TCR TG SCID were used in the surrogate model, paper 1. 
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Id-specific T cell - B cell interactions if naturally occurring, could include either a 
mono- or bispecific T cell as 15-30% of peripheral T cells normally have dual  expression 
(222,223).   
To exclude the possibility of Id-specific CD8+ T cells confounding our results, 
these were always removed when lymph node (LN) cultures from TCR TG BALB/c were 
used ex vivo. In paper 1, both TCR TG BALB/c and TCR TG SCID were used as 
recipients. For TCR TG BALB/c, we cannot exclude that Id-specific CD8+ T cells had a 
minor dampening effect on the recorded responses, due to cross presentation. However for 
TCR TG SCID the number of Id-specific CD8+ T cells are severely reduced compared to 
TCR TG BALB/c (218), so the effect would be negligible.  
 
Anti-Id DKI (paper 3) 
Unlike the TCR TG mice described above, the anti-Id BCR mouse generated in 
paper 3, is a targeted transgenic: rearranged Ig genes are targeted to positions in their 
native Ig loci. With the insertion of a rearranged VDJ or VJ gene sequence into its 
physiological position in the Ig locus, we obtained a single gene copy under the control of 
endogenous cis-acting DNA elements that naturally control expression.  
The HC VDJ anti-Id gene sequence was inserted into the Ig locus, by exchanging it 
with the unrearranged DQ52J region (essentially as previously performed (224)). In doing 
so, all endogenous J genes were removed. In theory this exchange of gene sequences 
should exclude endogenous rearrangements, as recombination signal sequences (RSS) 
were removed (although a rare endogenous rearrangement using cryptic RSS in the 
inserted V gene could occur (225)).  
For LC VJ anti-Id, our strategy was targeting the VJ of anti-Id into the  locus, but 
leaving the endogenous J 3-5 intact (essentially as previously performed (226)). This 
would in theory not exclude endogenous rearrangement from upstream V genes. 
However, this was not a major event, since in our anti-Id double knock-in (anti-Id DKI) 
almost all peripheral B cells expressed the anti-Id specificity. Even in old mice, almost all 
B cells expressed the anti-Id BCR. Thus allelic exclusion of endogenous HC and LC Ig 
genes was efficient and endogenous gene rearrangement probably very low frequent.  
The peripheral anti-Id B cells exhibited a normal surface density of BCR, IgM and 
IgD. The peripheral B cell pool in anti-Id DKI had a normal B cell subset distribution. The 
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only abnormal feature observed in the anti-Id DKI, was an enhanced developmental state of 
bone marrow B cells, as previously reported (227).  
 
Targeting Id+ to IgD, a surrogate model for T cell - B cell collaboration (paper 
1) 

In paper 1 we used a surrogate model for Id-specific T cell - B cell collaboration. In 
this model, we used IgDa-specific recombinant Ig (rIg) with Id+ peptide inserted into the 
CH1 domain of human 3 HC (228). Together with Id-specific T cells and HC allotype a B 
cells, Id-specific T cell - B cell collaboration could be studied. However this T cell - B cell 
collaboration is not “linked”, as there are no bona fide Id+/anti-Id interactions involved.  
In vitro, anti-Id A20 with Id+ Ig was x104 more efficient at inducing Id-specific Th2 
proliferation compared to the non - transfected A20 with Id+Ig (paper 1). It was previously 
demonstrated that A20, expressing hapten 2,4,6-trinitrophenyl (TNP) specific membrane 
IgDa, with Id+ rIg was x103 more efficient at inducing Id-specific Th2 proliferation 
compared to the control A20, expressing TNP specific membrane IgMa, with Id+ rIg (228). 
The IgD levels on anti-Id A20 and anti-TNP A20 were only investigated using anti-IgD 
Abs in flow cytometry (paper 2 and (229)) and not exactly quantified. Thus it is possible 
that anti-Id A20 has a slightly higher membrane IgD expression than anti-TNP A20, and 
thus an increased ability to stimulate Id-specific T cells.  
In vitro, for normal B cells, anti-Id B cells with Id+ Ig were x103 more efficient at 
inducing Id-specific Th2 proliferation than control BALB/c B cells with Id+ Ig (paper 3). 
IgD a B cells from BALB/c, with Id+ rIg revealed a 100-1000 fold increased efficiency at 
inducing Id-specific Th2 proliferation compared to the control B cell, IgDb from C.B-17, 
with Id+ rIg (228).  
These results show that both the surrogate model using Id+ rIg targeted to IgD 
(paper 1) and the bona fide “linked” Id-driven T cell – B cell model (paper 1 and 3) are 
both efficient at inducing Id-specific T cell proliferation. The M315 mAb (Id+ Ig), is an 
IgA (197). If Id+ Ig was of another isotype, the anti-Id B cell activation and subsequent Id-
specific T cell activation could be even more pronounced: IgM would have high avidity 
and thus increased ability to crosslink BCR and IgG isotypes could cross-link FcRs. Or, if 
the inhibitory FcRIIb was engaged, B cell activation could be reduced (230). 
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A20 B lymphoma cells (paper 1 and 2) 

A20 cells are easy to transfect and culture. The A20 cell line, as other B lymphoma 
cell lines has different growth capacities than normal B cells. Thus it could be a concern 
that the A20 signaling apparatus differs from normal B cells. However, A20 cells have 
been used as normal B cells in numerous BCR signaling experiments (231-233). A20 B 
lymphoma cells have also been used to study B cell antigen processing and presentation 
(228,234). Other murine B lymphoma cell lines have frequently been used to study BCR 
mediated apoptosis (235,236). So although it would have been preferable to perform all 
our experiments with normal B cells, it seems A20 is an acceptable replacement. Results 
from paper 1 and paper 2 suggest that A20 may have an enhanced capacity to stimulate Id-
specific T cells with Id+, compared to normal B cells. We investigated A20 B lymphoma 
cell surface marker expression in response to idiotypic stimulation (paper 1 and 2). 
However as we did not do this in parallel for normal B cells, it is difficult do say if the up 
or downregulation of cell surface markers was within the normal range. 
 
 IgD as an Id+/anti-Id receptor on A20 (paper 1 and 2) 

The A201.11 has endogenous membrane bound IgG2a (237), and no membrane 
bound IgM, IgA (238). We transfected A201.11 with Id+ or anti-Id membrane bound IgD. 
This gave B lymphoma cells that expressed Id+ or anti-Id membrane bound IgD with 
endogenous membrane bound IgG2a. We assume that endogenous membrane bound IgG2a 
did not effect our results greatly, as it has no specificity for our Id+ or anti-Id Ig. 
Naturally IgD is co-expressed with IgM on peripheral mature B cells. Would the 
presence of idiotype specific (Id+/anti-Id) membrane bound IgM on our transfected A20 
cells significantly change the results we obtained for antigen processing and presentation, 
and for apoptosis induction, in paper 1 and 2 respectively ? 
IgD function is still somewhat enigmatic. The protein structure of IgD and IgM is 
similar. The same signaling Ig-/Ig- heterodimer is coupled to both membrane bound IgD 
(mIgD) and membrane bound IgM (mIgM). The mIgM and mIgD molecules have the same 
cytoplasmic tail consisting of only three amino acids (1). The cytoplasmic components of 
the mIgM/I-Ig- and mIgD/I-Ig- antigen receptor complexes should thus be identical. 
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Some reports demonstrate that early events in signal transduction are similar for 
mIgD and mIgM (239,240). However the downstream effects of this signaling may vary. 
In experiments with B lymphoma cells expressing mIgM and mIgD, cross-linking of 
mIgM induced growth arrest, whilst cross-linking of mIgD did not induce growth arrest 
(241). Also there are reports of tolerance-induction and apoptosis of B cells differing, 
depending on the presence or absence of mIgD. In experiments using transgenic mice with 
anti-TNP mIgM B cells, addition of TNP caused deletion of the self reactive B cells. 
Whilst in transgenic mice that carried an additional  transgene, TNP addition did not 
cause deletion of the self-reactive B cells (242), implying that sIgD interfered with 
tolerance induction. In a mouse model for rheumatoid arthritis one transgenic mouse 
expressed self reactive B cells with mIgM and mIgD and another transgenic mouse 
expressed self reactive B cells with only mIgM. When exposed to antigen, B cells in mice 
with self reactive mIgM only B cells were deleted. Self reactive B cells in mice expressing 
mIgD and mIgM were resistant to deletion (243). This suggests that mIgD can increase the 
threshold for negative selection, by modulating signal strength. It appears that although 
structurally similar, the effect of signaling through mIgM or mIgD is different, at least in 
terms of growth inhibition and tolerance induction.  
Even though our Id+ A20 and anti-Id A20 cells only express Id+- and anti-Id mIgD 
respectively (not Id+ or anti-Id mIgM), they are indeed susceptible to apoptosis (paper 2). 
Given the above observations, the addition of Id+ or anti-Id mIgM to our A20 cells might 
enhance apoptosis.  
Different from the above experiments investigating the loss of mIgD, experiments 
have been performed where the consequence of mIgM loss was investigated. Here B cells 
expressing only mIgD were compared with normal mIgM/mIgD expressing B cells. These 
experiments demonstrated that mIgD largely can substitute for loss of mIgM. B cells with 
only mIgD supported normal B cell responses, including isotype class switching during 
immunization or infection (244). So it is possible that our Id+- and anti-Id mIgD expressing 
A20 cells can use mIgD to substitute for mIgM functions. Thus, the effect of adding Id+ 
mIgM to our Id+ mIgD expressing A20 cells, and anti-Id mIgM to anti-Id mIgD expressing 
A20 cells, may not greatly effect the outcome in terms of apoptosis or antigen processing 
and presentation. 
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Purification of Abs (paper 1,2,3). 

In paper 1 recombinant anti-IgD Ig with Id+ peptide was isolated from supernatant 
of transfected cells and purified on a protein G column. The resulting recombinant Ig 
preparation would contain bovine Ig as well. This is a concern as bovine Ig could bind to 
FcR and influence results. The NIP controls were purified on a 4 hydroxy-3 
nitrophenacetyl (NP) column, and should contain no bovine Ig.  
Recombinant anti-IgD Igs with different antigenic T cell epitopes integrated, have 
been purified on both protein L and protein G columns. Protein L columns do not bind 
bovine Ig. Results with these recombinant Ig preparations were the same (not published). 
Thus bovine Ig contamination in recombinant anti-IgD preparations should not be a 
problem. 
M315 (, 2) mAb, Id+ Ig and isotype control M460 (, ) mAb, Id- ctrl Ig, were 
isolated based on their capacity to bind DNP ligands (245). Thus, the isolated Ig should be 
bovine Ig free.  
 
B cell activation signals in vitro (paper 3)  

The activation state of both B cells and T cells is an important consideration for 
paper 3. As we wanted to determine the sensitivity of the Id-specific T cell - B cell 
collaboration, both B and T cells used should be naïve and non-activated.  
All the mice we used were kept in a pathogen monitored environment at our animal 
facility. Both B and T cells should be naïve in the sense that they had not been exposed to 
antigen (except for Id-specific Th2). However as B cells in some experiments were 
purified with anti-CD19 beads, it could be argued that this induced B cell activation. If so, 
the B cell could have an enhanced capacity as an APC. It has been demonstrated that 
ligating IgM can induce upregulation of the B7 marker (246). B7 is associated with an 
enhanced B cell activation state (247). 
CD19 is part of a signaling complex (248), and mobilizes intracellular calcium by 
mAb cross-linking of CD19 and co-receptors known from the BCR activation pathway 
(249). B cell antigen-specific activation is enhanced by the CD19/CD21/CD81 complex 
(250). However selective ligation of CD21 inhibits BCR mediated activation (251). Also 
selective ligation of CD19 can down-regulate signaling and inhibit proliferative responses 
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(252,253). It does not seem very likely that purification of B cells by using anti-CD19 
beads would induce an enhanced activation state of the cells.  
There were no great differences in Id-specific T cell proliferation responses induced 
by B cells either positively selected (CD19) or purified by negative depletion. Also if 
purification of B cells with anti-CD19 mAb induced an enhanced activation state of the B 
cells, we should have observed better Id-specific T cell responses for BALB/c B cells with 
Id+ Ig.  
 
Activation of naïve Id-specific T cells in vitro (paper3) 

Naïve Id-specific T cells were used as CD8 depleted LN cultures from TCR TG 
BALB/c in some in vitro experiments. One could argue that these T cells could be 
activated by other APC than anti-Id B cells. However when such Id-specific T cell cultures 
were incubated with Id+ Ig, but no anti-Id B cells, there was no Id-specific T cell 
proliferation (not shown). 
 
Activation of naïve Id-specifc T cells in vivo (paper 3) 

Adoptive transfers with naïve Id-specific T cells, anti-Id B cells and Id+ Ig resulted 
in Id-specific T cell proliferation. The level of T cell proliferation was absolutely 
dependent on anti-Id B cells being present. Our in vitro results suggest that the Id-specific 
T cell - B cell collaboration takes place in absence of other APC. However, in vivo in 
BALB/c recipients, we cannot rule out, that endogenous APCs to some degree could prime 
and activate Id-specific T cells. This could be ruled out by transferring purified Id-specific 
naïve T cells and anti-Id B cells with Id+ Ig to an immune-deficient mouse strain with 
another MHC class II haplotype than BALB/c (H-2d). In this way highly purified Id-
specific T- and anti-Id B cells could be transferred into recipients lacking the required 
MHC class II for presentation of Id+ to Id-specific T cells. 
  
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Sensitivities of ELISA (paper 3) 

In paper 3 we wanted to determine a lower threshold for cells and Id+ Ig that could 
induce an Id-specific T cell - B cell response. Our most sensitive read-out was ELISA, 
measuring isotype switched anti-Id Abs in serum. An unexpected result, was that IgG2b 
was the most dominant anti-Id Ab isotype as a result of anti-Id B cells, Id-specific T cells 
and Id+Ig interacting in vivo. From this given interaction, T helper cell responses should be 
expected. Th1 and Th2 promote mainly B cell isotype switching to IgG2a and IgG1 
respectively (254). Tfh largely promote B cell isotype switching to IgG1 (255) and Th17 
promote B cell isotype switching to IgG2a and IgG3 (256). Thus, it is likely that our 
ELISA parameters are not optimal, resulting in different detection sensitivities for the 
different Ig isotypes. Possibly the “linked” Id-driven T cell – B cell interaction is relevant 
at even lower numbers of cells and Id+ Ig than we have estimated based on ELISA 
readouts. 
 
 
 
 
 
 






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
DISCUSSION 

The theme for this thesis is Id-driven interactions of specific T- and B cells, either 
B - B or T - B. We propose that these interactions play a part in regulating idiotype 
networks. We show in a surrogate model that anti-Id B lymphoma cells are very efficient at 
inducing Id-specific Th cell functions in the presence of Id+ Ig (paper1). We demonstrate 
that idiotype specific B - B interactions, could reduce the B cell repertoire, and thus 
idiotypic connectivity (paper 2). In paper 3 we present a physiological model for “linked” 
Id-driven T cell - B cell collaboration. We demonstrate in vivo, that this type of 
collaboration is highly sensitive for inducing anti-Id isotype switched Abs in response to 
non-adjuvanted Id+ Ig.  
 
BCR diversity 

Clonally distributed BCRs have extremely diversified variable (V) regions due to 
random recombination of V(D)J gene segments, junctional diversity and somatic 
hypermutation (257). About 108 B cell lineage precursors are generated daily in murine 
bone marrow, resulting in 2x107 immature membrane IgM expressing B cells (258). Given 
this high output of B cells with randomly generated BCR, self-reactive B cells should arise 
frequently (11). In fact monoclonal antibodies cloned from single purified B cells show 
that 55 to 75% of all antibodies expressed by early immature B cells display self-reactivity 
(259). Most of these are removed at checkpoints, some as immature B cells in the bone 
marrow, others as transitional/new emigrant B cells (259). However some self reactive B 
cells escape tolerance induction and are present in the periphery (20). 
 
Idiotypes and the idiotypic network 

As a consequence of BCR diversity, individual Ig molecules carry unique V region 
antigenic determinants that are called idiotopes (104-106). Idiotopes can be recognized by 
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other antibodies in the individual. This is illustrated by high idiotypic connectivity in 
neonates (260) and also in adults (261).  
 Based on several early experiments (see introduction “the idiotypic 
network”) N.K Jerne postulated that the immune system functions as a network based on 
idiotypic interactions between lymphocytes expressing complementary BCRs (108). 
However T cells were not integrated into this model. 
 
T cell tolerance to immunoglobulin V regions 
 
It has been demonstrated that APCs process and present Ig V-region derived 
idiotypes on MHC class II molecules to Id-specific CD4+ Th cells (199,200,262). Further, 
it has been demonstrated that B cells process endogenous BCR and present Id peptides on 
MHC class II (78,192,263). 
 If naïve T cells responded to all idiotypes, there would be uncontrollable 
autoimmunity, so this is obviously not the case. Several restrictions apply. There are 
limitations to the Id peptides that can be presented on MHC class II (201). The frequency 
of CD4+ T cells with TCR able to recognize Id may be low, due to restricted TCR use 
(264). Also Tregs may have a dampening effect. Further, the diversity of Id peptides 
available for T cell recognition, is much lower than the diversity of idiotypes available to B 
cell recognition. This is so because T cells recognize sequence determinants while B cells 
recognize conformation determinants to which Ig H and L chain pairings contribute. Also 
T cells appear to be tolerant to germline Id, and only recognize either somatically mutated, 
or non-germline sequences (N region diversity) (200,265,266). Tolerance induction of Id-
specific peripheral T cells may also arise in a concentration dependent way, as shown for 
myeloma protein in myeloma protein specific TCR transgenic mouse (267). Despite all 
these restrictions, expanded pools of idiotype specific T have been shown to exist in 
humans with diseases such as SLE (268), rheumatoid arthritis (269) and multiple sclerosis 
(270). 
 
“non-linked” Id-driven T cell - B cell collaboration  

B cells process endogenous BCR and present Id peptides on MHC class II 
(78,192,263). An experimental model with Id-specific Th cells from TCR transgenic mice 
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(202) and Id+ B cells from BCR 2315 transgenic mice (271) demonstrated that, Id+, 2315 
expressing B cells, in absence of ordinary antigen, isotype switch and enter GC reactions, 
in the context of Id-specific Th cells (194). This T cell - B cell interaction has been termed 
“non-linked” Id-driven T cell - B cell collaboration (see introduction for details). Chronic 
T cell stimulation of B cells in the “non-linked” Id-driven T cell - B cell collaboration, can 
lead to B cell lymphoma development (195) and SLE (196).  
 
“linked” Id-driven T cell - B cell collaboration 

It has been demonstrated that B cells can present exogenous Ig Id in a MHC class II 
restricted fashion to Id-specific T cells (200). However, in this system spleen APCs were 
used, thus no anti-Id BCR was present. We show (paper 1 and 3) that using normal B cells 
with anti-Id BCR, Id+ Ig is efficiently processed, and presented to Id-specific Th cells 
eliciting Id-specific Th cell and anti-Id B cell effector functions. This Id-driven T cell - B 
cell collaboration is “linked” in the sense that the BCR and the TCR recognize components 
from the same antigenic entity (Id of the Ig). 
 
Tolerance induction to self-reactive idiotypes. Id+ A20 and anti-Id A20 induce 
unidirectional apoptosis mediated by BCR/BCR interactions.  

What would happen if an Id+ B cell and an anti-Id B cell were to encounter? To 
answer this we generated B lymphoma cells with idiotypically complementary BCRs.  
As a mechanism of tolerance induction, it has been demonstrated that high affinity 
BCR interactions with self-antigen induce apoptosis (272). In paper 2 we observed 
apoptosis for Id+A20 and anti-Id A20 when interacting in a BCR/BCR specific manner. 
Also anti-Id A20, with a higher BCR density than Id+ A20, was induced to undergo 
apoptosis when incubated with Id+ Ig. By contrast, we could not observe any significant 
apoptosis for Id+A20 incubated with anti-Id Ig. This is consistent with previous findings 
showing that BCR density (overall binding-capacity) influences the kinetics of apoptosis 
for B cell: B cells with high density of self reactive BCR are more prone to apoptosis than 
B cells expressing lower density of self-reactive BCR (273,274). 
42

Previous reports show that BCR mediated binding to membrane bound self-antigen 
is more potent at inducing signaling than BCR binding to soluble self-antigen 
(205,275,276). This was supported by our findings. For the Id+/anti-Id BCR/BCR 
interaction, we demonstrated that both cells are capable of undergoing apoptosis. However, 
overall, Id+ A20, with comparatively lower BCR density, was more susceptible to 
apoptosis. An additional finding, was that only one of two interacting cells received a 
caspase 3 apoptotic signal. These observations are puzzling. 
It is difficult to speculate how the above mentioned events arise. Experiments using 
B cells interacting by idiotype specific BCR/BCR interactions, have not been performed 
previously. Experiments have been done with Hen Egg Lysozyme (HEL)-specific B cells 
and HEL conjugated to an immobilized membrane, or to HEL expressing cells (48,277). 
These experiments show that when the HEL-specific BCR meets membrane bound HEL, 
HEL will be gathered into a defined cluster by the HEL-specific B cell spreading its 
membrane over the target membrane. This membrane spreading first generates several 
micro-clusters of BCR/antigen, and then contracts into a focal point gathering all the 
smaller clusters into one bigger cluster (48). Below a certain threshold of HEL antigen, 
there is no B cell membrane spreading and thus no signaling (48). In our case the 
conventional HEL antigen would be Id+ BCR or anti-Id BCR. If antigen density, or BCR 
density in our case, is a determining factor, then there could be a skewing towards Id+A20 
spreading its membrane over anti-Id A20, and not the other way around. Anti-Id BCR 
could then be gathered into signaling micro-clusters, and subsequently into one larger 
cluster. Anti-Id would also be capable of initiating the membrane spreading, but this event 
would probably be less frequent, due to the decreased likelihood of anti-Id BCR sensing a 
Id+ BCR dense membrane surface area. 
The term trogocytosis, defines the intracellular transfer of plasma membrane 
between cells of the immune system (278). Recent reports have demonstrated that B 
lymphoma cells (279) and normal B cells (280) have the capacity to transfer membrane. It 
has been demonstrated that two normal B cells can efficiently transfer BCR between each 
other (280). It has also been proposed that capture of such membrane components from 
one cell to another, can confer sustained intracellular signaling for the cell that captures 
membrane components (hypothesized for T cells interacting with APCs (281)). 
All taken together, I speculate, that in the majority of encounters, Id+A20 will 
spread its membrane over anti-Id A20, triggered by the higher BCR density of anti-Id A20. 
Speculatively, due to this directional skewing of the membrane interaction, Id+A20 could 
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trogocytose membrane from anti-Id A20 and internalize anti-Id BCR which could lead to 
sustained intracellular signaling for Id+A20. This would finally send a caspase signal to 
Id+A20 (the possible process is illustrated in Figure 11). We have observed trogocytosis-
like cell morphology in our Id+/anti-Id BCR/BCR interacting cells, see Figure11.  
Following the possible explanation above, the remaining anti-Id A20, having lost 
BCR/membrane components, could have lost the potential to reach the BCR activation 
induced threshold level of Ca2+ needed for apoptosis (282). This could explain the 
unidirectional caspase activation signal. 
 Isolating cellular interactions that could demonstrate the speculative explanation 
given above is difficult, as the cells interact in clusters with different numbers of cells. 
However the fact that cells interact in single conjugates and larger clusters, does not 
exclude the above explanation. 
 
 
Three known self-tolerance mechanisms regulate autoreactive B cells: apoptosis, receptor 
editing and anergy (272,275,283-285). These individual models predict that BCR ligation 
leads to vastly different outcomes for the B cell. Several factors can influence the outcome; 
Figure 11. A mechanism explaining the overall 
sensitivity of Id+A20 to apoptosis? 
A. Id+A20 spreads its membrane over the BCR 
dense anti-Id A20, left. Id+A20 trogocytoses 
membrane from anti-Id A20 and receives 
caspase signal, right. B. anti-Id A20 labelled 
with the membrane marker PKH26 and Id+A20 
labelled with CFSE. 1.Id+A20 membrane 
spreading? 2.Id+A20 trogocytoses membrane 
fom anti-Id A20? Or anti-Id A20 spreading it’s 
membrane over Id+ A20? 
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ligand affinity (205,275,276), expression of mIgM as B cells mature (286), or extrinsic 
factors delivered by the microenvironment (206). So hypothesizing an outcome for normal 
B cells engaged in idiotype specific BCR/BCR interactions is difficult. However it seems 
likely that the idiotype specific BCR/BCR interaction with ensuing apoptosis could 
illustrate a tolerance mechanism for ridding the body of self reactive B cells, in a selective 
manner. In our case the selective advantage is conferred by a higher BCR density. B cells 
in the periphery are highly dependent on the BCR for survival (287). So possibly the 
selective apoptosis we describe could serve to eliminate B cells with a lesser capacity to 
receive BCR survival signals. 
 
Examples of idiotypic connectivity 
 
Self reactive B cells, as discussed above are normally eliminated by tolerance 
mechanisms. However B cells that are self reactive to other Ig idiotypes, often seem to 
escape tolerance mechanisms. This is demonstrated by the high idiotypic connectivity in 
neonates (260), by the induction of anti-Id Abs in individuals immunized with monoclonal 
Ig (106) and by the presence of anti-idiotypic Abs towards pathogenic autoantibodies in 
healthy individuals (122,123). 
It has even been demonstrated that immunization with Ig can potently elicit cascade 
reactions of idiotypes (all escaping tolerance), leading to Ig present in a sufficient 
concentration to kill tumors. Gangliosides are expressed on tumors (288,289). When non-
small lung cancer patients were immunized with a murine anti-idiotypic mAb specific for 
an idiotypic mAb reacting with N-glycolyl containing-gangliosides, a tumoricidal effect 
was observed in patients (290). In a similar model a tumoricidal effect was obtained with 
mAb directed to p53 antigen in immunized mice. The immunized mice produced IgG 
antibodies to p53 and mounted a cytotoxic reaction to a tumor-line bearing mutated p53 
(291).  
In both experiments, tumoricidal IgGs resulted (126,291). This possibly means that 
the tumoricidal IgGs arise from a GC reaction (292). GC reactions could lead to idiotypes 
with highly mutated Ig V regions (292). B cells expressing such highly mutated self 
reactive Igs could escape tolerance mechanisms (293). 
 

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Lack of tolerance to B cells expressing self reactive non-germline idiotypes. Id+ 
Ig M315 mAb and anti-Id Ab2-1.4 are non germline idiotypes. 
 
Id+ Ig mAb M315 used in our system, has the rare 2 isotype (294). Also it has 
somatic mutations in this  chain in position 94, 95, 96, conferring aa substitutions from 
Tyr, Ser, Thr to Phe, Arg, Asn (294-296). Anti-Id mAb Ab2-1.4 (297) is also heavily 
mutated leading to aa substitutions. Ab2-1.4 VH has somatic mutations leading to 9 aa 
substitutions and additional N-region nucleotides leading to 3 additional aa (paper 3). 
When mice were hyper-immunized with Ab2-1.4 mAb, M315 like Abs were generated 
(298). This could suggest that an Ig V(D)J with a high degree of somatic mutations, N-
region additions or imprecise joining of gene elements, could lead to rare idiotypic variants 
that would escape deletion. Lupus prone mice mice that are defient for Terminal 
deoxynucleotidyl transferase (TdT), which adds nontemplate coded nucleotides (N-region 
additions), have a decrease in autoantibodies (299). This suggests that N region nucleotide 
additions alone, could be enough to create tolerance escaping clones.  
It has been suggested that whilst there is tolerance towards the abundant germline 
idiotypes, the rare e.g somatically mutated versions will be of such low concentration that 
they cannot induce tolerance in the same way (300). Could it be that such rare idiotypes 
would not have been presented to T cells, during the development of central tolerance and 
thus such specific T cells could be activated in the periphery. If this is the case, one could 
speculate that idiotypic connectivity is different depending on different B cell subsets. 
 
A speculative model for idiotypic connectivity defined by B cell subsets 
Follicular B2 cells constitute the majority of B cells in spleen (~70%) (22). These B 
cells depend on Tfh cells in order to become effector B cells. When they receive Tfh cell 
help, they can aquire somatic hypermutations in V genes, isotype switch and produce high 
affinity Abs (88). B-1 cells, either B-1a or B-1b constitute 2% and <1%, respectively of B 
cells spleen (301). B-1 cells mainly reside in peritoneal and pleural cavities (constituting 
35-70% of cells) (22). B1-a cells have unmutated V regions, and express very few if any 
N-region substitutions in their CDR3 region (302). B1-b cells by contrast contain N-region 
additions in their CDR3 sequences (303). MZ B display N region diversity in CDR3, but at 
a lower level than for B2 follicular B cells, as well as displaying V gene somatic 
hypermutations (304,305). In contrast to the follicular B2 cells, B1 and MZ readily 
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proliferate in response to lipopolysaccaride (LPS), reviewed in (27). In this T-independent 
fashion, they have features of innate immunity (reviewed in (27)). B-1 cells can even 
spontaneously secrete IgM (306). Last but not least, B-1 cells and MZ B cells are enriched 
for self reactive clones that also can bind bacterial antigens (33,307). B1 cells produce low 
affinity IgM and act early on in the immune response, in comparison to B2 cells that act in 
the adaptive immune response and can generate high reactive clones (301). In light of all 
this, cold it be that B cells, depending on their subset, have different idiotypic 
connecitivity? 
Perhaps B-1a cells with a low threshold for T-independent activation and 
subsequent Ig secretion, expressing low affinity self Ig, have a web of self-idiotype 
reactive low affinity Igs. These Igs would have germline encoded idiotypes of such 
abundance that T cells would be tolerized to them. A similar, but reduced idiotypic 
connectivity could exist for MZ B cells, also able to secrete Ig T-independently. MZ B 
cells would have a higher degree of idiotypic diversity, provided by N-region substitutions 
and somatic mutations. Given this larger idiotype diversity, clones with higher affinity for 
self idiotypes, could arise. Of interest, MZ B cells show pronounced IgM induced 
apoptosis, which is not present for B-1 cells, and to a lesser extent for follicular B2 cells 
(31,308). This could illustrate a need to get rid of possible self reactive clones of high 
affinity. Speculatively, for B-1 cells and MZ B cells, low affinity IgM interactions would 
supply a network of idiotype connections.  
Finally we have the bulk of the splenic B cells, follicular B2 cells. Follicular B2 
cells require Tfh cell help to expand in response to antigen. In the absence of adequate Tfh 
cell help during B cell priming, follicular B2 cells arrest in the T-cell zone after binding 
antigen and undergo apoptosis rather than differentiation into GC B cells or antibody-
forming plasma cells (309,310). Thus almost all follicular B2 cells reacting to germline Id 
would die as Tfh cells would be tolerized to these abundant self-idiotypes. However it has 
been demonstrated that MZ B cells can shuttle between the marginal zone and the B cell 
follicle containing follicular B2 cells (311). So speculatively, a MZ B cell expressing an N-
region substituted, somatically hypermutated Ig, could be recognized by a follicular B2 
cell. The latter cell could present peptides to an Id-specific Tfh cell. This Id-specific Tfh 
cell would not have encountered such a non-germline idiotype during development of 
central tolerance and thus be responsive. Subsequently, the Id-presenting B cell would 
become an effector B cell secreting anti-idiotypic antibodies. Under normal circumstances 
this would probably not happen, as there would have to be a sufficient concentration of 
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non-germline Id present to initate the “linked” Id-driven T cell- B cell collaboration 
described. However if e.g LPS provided a help signal for the initiating MZ B cell, this 
could increase the concentration of the N-region substituted, somatically hypermutated Ig 
to a sufficient concentration to initiate the “linked” Id-driven T cell- B cell collaboration. It 
has been suggested that there is a link between bacterial infection and SLE (312). Maybe 
the expansion of non-germline Id expressing MZ B cells under the influence of bacterial 
derived LPS could trigger an expansion of high affinity anti-idiotypic B cells capable of 
binding DNA. If the infected individual had a reduced capacity to clear bacteria, e.g a 
complement deficieny, this could increase the level of the activating LPS.  
If the follicular B2 cell producing anti-idiotypic Ig to MZ B cell Ig, receives 
sufficient Id-specific Thf help, then the follicular B2 cell could produce somatically 
hypermutated Ig. This Ig could be presented to another Id-specific Tfh cell by “non-linked” 
T cell- B cell collaboration. Thus there could be expansion of several high affinity Ig 
producing follicular B2 cells. It has been shown that chronic “non-linked” Id-driven T cell- 
B cell collaboration can lead to SLE with the production of the disease related 
autoantibodies (196). Such antibodies are somatically hypermutated (293).It has also been 
demonstrated that there is an explosion of autoantibodies in SLE patients, many of which 
are correlated with diseae activity (313). How “linked” and “non-linked” Id-driven T cell-
B cell collaboration could work in concert will be discussed further on. See Figure11 for an 
illustration of the speculative network of idiotypic interactions, depending on B cell 
subsets. 
The mechanism for how non-germline idiotype producing B cells are expanded by 
help from non-tolerized idiotype-specific Tfh cells, could explain how the introduction of 
exogenous idiotypes, readily can initiate idiotype cascades and result in high 
concentrations of Ig capable of killing tumors (314).  
In addition to Ig V genes being somatically hypermutated during the GC reaction 
(315), non-Ig genes can also be mutated in this process (316). Mutations in the CD95 gene, 
implicated in negative selection of GC B cells, frequently arise in parallel with somatic 
hypermutation, and may lower the threshold for self reactive clones arising (317).  
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Figure 11. Possible distribution of Id/anti-Id interactions between different B cell subsets. Dots signify cells. 
Lines signify an Id/anti-Id interaction. Dots do not represent a realistic distribution of cells in each B cell 
subset population. Possibly B1a cells (center, green) have a high degree of idiotypic low affinity 
connectivity. The number of Id/anti-Id interactions could be decreased for MZ B cells (middle, blue), and 
further reduced for B2 follicular B cells (outer zone, red). The affinity of the interactions could be reversly 
proportionate to the frequency of interactions, with B1a cell Id/anti-Id interactions being high frequent but 
low affinity and follicular B2 cell Id/anti-Id interactions being very low frequent, but of high affinity. 
However during autoimmune disease there could be a break-down of Id-specific Thf cell tolerance, resulting 
in the generation of several high affinity Ig idiotypes. 
 
Naïve Id-specific T and naïve anti-Id B are sufficient to respond to Id+Ig 
 
Data in paper 3 demonstrates that naïve anti-Id B cells and naïve Id-specific T cells 
are sufficient in the presence of Id+ Ig to initiate anti-Id B cell responses. Classically B 
cells have not been regarded as very efficient APCs. B cell deficient mice have a normal 
capability of T cell priming (318). However this was shown in lack of a BCR specific for 
antigen. Tetanus toxoid specific B cells have been shown to trigger T cell proliferation at 
104 x lower Ag concentration than non-specific B cells (319). Also it has been shown that 
specific B cells are required for systemic T cell priming at low antigen concentrations 
(320). 
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 Previous findings show that naïve B cells require an activation signal in order to 
activate naïve T cells (321). Experiments using HEL specific naïve T and B cells show that 
BCR mediated stimulation, activating the BCR complex (up-regulation of B7 co-
stimulatory molecule), is a sufficient activation signal for rendering the B cell capable of 
stimulating T cells in vitro (322). We here show that anti-Id B lymphoma cells exhibit x104 
capacity to stimulate Id-specific T cells in vitro (paper 1). In vivo Id+Ig binding to anti-Id 
BCR induces a highly efficient stimulation of naïve Id-specific T cells (~130 ng/ml Id+ Ig).  
If naïve T cells and naïve B cells with small amounts of Id+ Ig are enough to induce 
anti-Idiotypic responses, this could lower the threshold for self-reactive anti-Id idiotypes 
escaping tolerance.  
 
 
Combining the “Non-linked” and “Linked” Id-driven T cell - B cell 
collaboration in one model 

The “linked” Id-driven T cell - B cell collaboration described in paper 1 and 3 
needs to be integrated into one model with “non-linked” Id-driven T cell - B cell 
collaboration (see Figure7 paper 1 and extensive discussion paper 1). How “linked” and 
“non-linked” Id-driven T cell- B cell collaboration can work in concert was briefly 
discussed above in “A speculative model for idiotypic connectivity defined by B cell 
subsets”. However the sum of interactions involved could be more complex than 
previously discussed. 
 An Id+ B cell (to the left in Figure 12) can process it’s endogenous monoclonal 
BCR and presents peptides on MHC class II to Id-specific T cells (i) (see Fig. 12 for 
symbols). Also BCR can be ligated by polyclonal anti-Id (ii) and iii), resulting in 
presentation of Id-peptides derived from endogenous Ig to several Id-specific T cells (T2, 
T3). This also applies to an anti-Id B cell (to the right in Figure 12). Thus the 
complementary Id+ B cell and anti-Id B cell are probably regulated by partly overlapping 
sets of Id-specific T cells. This is a simplification, and would be influenced by many 
factors: 1) different IgG isotypes would have different ability to bind FcRs, some would 
bind FcRIIb1 and deliver negative signals to the B cell (230), 2) different T cell subsets 
would have different effector functions (Th1, Th2, Th17, Tfh, Treg), 3) MHC class I 
restricted Id-specific CD8+ T cells could kill B cells, 4) CD4+ T cells seem tolerant to 
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abundant germline-encoded Id-peptides (200,265,323). However the last point could be 
circumvented by the introduction of somatic hypermutations/N-region substitutions in Ig 
Id-peptides being presented to T cells, as previously discussed. It could be argued that 
“linked” or “non-linked” Id-driven T cell B cell collaboration would create novel Ig V 
region mutations, destroying the T cell recognition of a given Id-peptide. However such 
mutated B cells could become subject to a novel sets of Id-specific T cells.  
The picture that emerges for Id-driven T cell- B cell collaboration is complex. 
However such interactions could explain findings such as 1) neutralizing anti-idiotypic 
antibodies against autoantibodies to blood group antigens (324), 2) the large expansion of 
multiple self reactive Ig clones related to disease activity during (325,326) and prior to 
(327) autoimmune diseases, 3) somatic hypermutations of Ig V genes driven by the Id 
specific T cells as a cause of disease specific autoantibodies in SLE (293), 4) lymphoma 
development, as chronic Id-specific Tfh cell help with subsequent somatic hypermutations 
of Ig V genes, could lead to mutations in proto-oncogenes (195,328), promoting lymphoma 
development. 
  
Figure 12. A revised idiotypic network model 
 
BCR/BCR mediated apoptosis as shown in paper 2 would necessitate close 
proximity of B cells, and not necessarily exclude the interactions shown in Figure 12. B 
cell -T cell pairing may be favored over B cell-B cell pairings. Also soluble Ig may act 
with B cells (Id+ Ig/anti-Id BCR and/or Id+ BCR/anti-Id Ig) in such an extent that the two B 
cells cannot interact in a BCR/BCR mediated fashion. 
51

  
FUTURE PERSPECTIVES 
 
“Linked” Id driven T cell  - B cell collaboration and lymphoma 
As shown for “non-linked” Id-driven T cell - B cell collaboration, chronic Id-
specific T-cell stimulation of Id+ B cells induces B-cell lymphoma (195). If supplied with 
chronic stimulatory signal, through BCR (through the Id+ Ig/anti-Id BCR interaction) and 
through Id-specific T cell help, would we observe the same for “linked” Id-driven T cell - 
B cell collaboration? It has been shown that BCR signal is instrumental in maintaining B 
cell lymphomas (329,330), thus it may well be that the proposed type of chronic 
stimulation could induce lymphoma development. 
 
“Linked” Id driven T cell - B cell collaboration in tumor prevention 
It has been demonstrated that Id-specific CD4+ T cells can confer tumor resistance 
to MOPC315 (218). Given the excellent capacity of anti-Id B cells as APC for Id-specific 
T cells in the context of Id+ Ig, would the presence of these B cells enhance the tumoricidal 
effect?  
 
Various forms of Id as a BCR ligand, and the effect on “linked” Id-driven T 
cell – B cell collaboration 
We are currently engaged in efforts to generate anti-Id, Ab2-1.4 specific T cells. 
Also a KI mouse for the HC of the Id+ mAb M315 is being generated. A cross between this 
mouse and the 2315 B cell transgenic mouse (271), would result in B cells expressing HC 
and LC of Id+ mAb M315. The BCR of this Id+ B cell could be ligated by the hapten 
dinitrophenol (DNP) for which M315 is specific. DNP could be conjugated at different 
ratios to small molecules (e.g. amino acids), macromolecules (proteins, carbohydrates), 
and even cells. Thus, a panel of antigens ranging from from monovalent to polyvalent 
could be easily generated. In addition to ligation with hapten, an M315-based Id+ BCR 
could be ligated by the anti-idiotypic mAb Ab2-1.4. This antigen comes in many forms 
since our group has already expressed V-regions of anti-Id mAb with i) H-chains of 
various Ig subclasses (IgM, IgG1, IgG2a, IgG2b, IgG3), ii) as BCR on B lymphomas 
(paper1) and (iii) in double KI B cells (paper 3). Moreover, Fab fragments of Ab2-1.4 
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could be used as monovalent antigen. In summary, a range of haptenated antigens and 
protein ligands of various valency are available. These could be used to experimentally 
vary the degree of ligation and cross-linking of the Id+ BCR, signaling of the B cell and 
presentation to anti-Id, Ab2-1.4 specific T cells. This could also be done with anti-Id B 
cells and Id-specific T cells, with different forms of Id+ ligand. 
 
Idiotypic B cell - B cell interactions, a physiological model 
 
Obtaining the Id+, M315 VH KI mouse would enable us to investigate the 
BCR/BCR complementary interaction of idiotypically paried B cells in a physiological 
manner. This is not trivial, since the B cells also express secretory Ig. However, labeling 
cells and using intravital multiphoton microscopy, we could perform adoptive transfers 
with different kintetics and study the outcome. 
 
A revised network model 
 
If we obtain anti-Id, Ab2-1.4 specific T cells and a VH 315 KI, we could 
investigate “linked” and “non-linked” Id-driven T cell - B cell collaboration 
simultaneously in one physiological model. We would have a model corresponding to that 
depicted in Figure12. Labeling cells and doing adoptive transfers with varying kinetics into 
recipient mice for intravital multiphoton microscopy could provide interesting data. 
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